Home › Funds › Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. › JANX

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. position in JANX

JANUX THERAPEUTICS INC · Health Care

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. reported holding 376,496 shares of JANX (JANUX THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$6.5M, representing 0.31% of its reported portfolio and ranking #29 among its reported holdings. Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. has disclosed JANX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)376.50K sh
Reported value held$6.51M
Portfolio Weight0.31%
First reportedQ3 2024
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.'s JANX position evolved

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. first disclosed a stake in JANX in Q3 2024 at 471,736 shares (US$21.4M). The position peaked in Q4 2024 at 429,392 shares, worth US$23.0M. Across 9 filings, Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 376,496 shares valued at US$6.5M.

Quarter by quarter

QuarterSharesValueChange
Q3 2024 471.74K $21.43M New
Q4 2024 429.39K $22.99M Reduce
Q1 2025 376.50K $10.17M Reduce
Q2 2025 376.50K $8.70M Hold
Q3 2025 376.50K $9.20M Hold
Q4 2025 376.50K $5.20M Hold
Q1 2026 376.50K $5.23M Hold
Q2 2026 376.50K $5.78M Hold
Q3 2026 376.50K $6.51M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JANX and 13F data

JANX (JANUX THERAPEUTICS INC) is a Health Care company. 27 other funds we track also report a position in JANX — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$171.9M), Prosight Management, LP (US$58.4M), TCG Crossover Management, LLC (US$27.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JANX

All JANX fund holders →

FAQ

How long has Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. held JANX?

Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. has disclosed JANX holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.'s current position in JANX?

As of Q3 2026, Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. holds 376.50K shares of JANX (JANUX THERAPEUTICS INC), valued at $6.51M, representing 0.31% of its reported portfolio and ranking #29.

Has Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. been buying or selling JANX?

In the latest 13F filing (Q3 2026), Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. held unchanged its position in JANX. The position peaked in Q4 2024 at 429.39K shares.

Which other funds hold JANX?

Other major institutional holders of JANX include RA CAPITAL MANAGEMENT, L.P., Prosight Management, LP, TCG Crossover Management, LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.